488 related articles for article (PubMed ID: 26242666)
1. Self-monitoring of blood glucose measurements and glycaemic control in a managed care paediatric type 1 diabetes practice.
Davey B; Segal DG
S Afr Med J; 2015 Apr; 105(5):405-7. PubMed ID: 26242666
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
Puhr S; Calhoun P; Welsh JB; Walker TC
Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
Raviteja KV; Kumar R; Dayal D; Sachdeva N
Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
[TBL] [Abstract][Full Text] [Related]
4. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
[TBL] [Abstract][Full Text] [Related]
5. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
6. Impact of Self-Monitoring Blood Glucose on Glycaemic Control Among Insulin-Treated Patients With Diabetes Mellitus in Northeastern Tanzania: A Randomised Controlled Trial.
Muhali SS; Muhali FS; Mfinanga SG; Sadiq AM; Marandu AA; Kyala NJ; Said FH; Nziku EB; Mirai TE; Ngocho JS; Mlay HL; Waria GG; Chambega A; Kessy SN; Kilonzo KG; Lyamuya FS; Mkwizu EW; Shao ER; Chamba NG
J Diabetes Res; 2024; 2024():6789672. PubMed ID: 38899147
[No Abstract] [Full Text] [Related]
7. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
8. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial.
Di Bartolo P; Nicolucci A; Cherubini V; Iafusco D; Scardapane M; Rossi MC
Acta Diabetol; 2017 Apr; 54(4):393-402. PubMed ID: 28138788
[TBL] [Abstract][Full Text] [Related]
9. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
10. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
[TBL] [Abstract][Full Text] [Related]
11. Effects of physician's diabetes self-management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self-monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open-labeled, prospective randomized clinical trial.
Tanaka N; Yabe D; Murotani K; Yamaguchi Y; Fujita Y; Kubota S; Nakashima-Yasuda R; Kubota-Okamoto S; Ueno S; Yamazaki Y; Kuwata H; Watanabe K; Hyo T; Hamamoto Y; Kurose T; Higashiyama H; Seino Y; Yamada Y; Seino Y
J Diabetes Investig; 2021 Dec; 12(12):2221-2231. PubMed ID: 34087060
[TBL] [Abstract][Full Text] [Related]
12. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
[TBL] [Abstract][Full Text] [Related]
13. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes.
Ziegler R; Heidtmann B; Hilgard D; Hofer S; Rosenbauer J; Holl R;
Pediatr Diabetes; 2011 Feb; 12(1):11-7. PubMed ID: 20337978
[TBL] [Abstract][Full Text] [Related]
14. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
15. Frequency of blood glucose testing in well educated patients with diabetes mellitus type 1: how often is enough?
Minder AE; Albrecht D; Schäfer J; Zulewski H
Diabetes Res Clin Pract; 2013 Jul; 101(1):57-61. PubMed ID: 23726303
[TBL] [Abstract][Full Text] [Related]
16. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
[TBL] [Abstract][Full Text] [Related]
17. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
Billings LK; Parkin CG; Price D
Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
[TBL] [Abstract][Full Text] [Related]
18. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
Nathanson D; Svensson AM; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
Diabetologia; 2021 Jul; 64(7):1595-1603. PubMed ID: 33774713
[TBL] [Abstract][Full Text] [Related]
19. Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy.
Spaans E; van Hateren KJJ; Groenier KH; Bilo HJG; Kleefstra N; Brand PLP
Eur J Pediatr; 2018 Dec; 177(12):1831-1836. PubMed ID: 30238153
[TBL] [Abstract][Full Text] [Related]
20. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
